Dr Lal Path Labs Ltd (LALPATHLAB)

Dr Lal Path Labs Ltd (LALPATHLAB) is listed on the NSE in the Healthcare Service Provider sector, Healthcare Services industry. Market capitalisation: 29657.24 Cr. Figures below are as reported and are shown with their source and date.

Educational use only — GoQuant is a research tool. This page lists company facts only and is not a recommendation. Investment advice is provided by FINOME TECHNOLOGIES PVT LTD (AltQube), SEBI-registered Investment Adviser, registration no. INA000018373, under a signed advisory agreement and after a risk profile. Past performance is not indicative of future results.

Company profile

Sector
Healthcare Service Provider
Industry
Healthcare Services
Market cap (₹ Cr)
29,657.24

Dr. Lal PathLabs Ltd. engages in the business of running laboratories for carrying out pathological investigations. The company is headquartered in Gurgaon, Haryana and currently employs 4,048 full-time employees. The company went IPO on 2015-12-23. The firm is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Company’s subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.

Source: finedge · as of 2026-09-29

Price, last year

Last close (₹): 1,843.7

Source: quantro_screener_metrics_job · as of 2026-10-22

Key figures

P/E
61.19
52-week high
2,038.6
52-week low
1,272.6
Revenue CAGR, 3 years (%)
11.06
Revenue CAGR, 5 years (%)
11.81
EPS CAGR, 3 years (%)
28.11
EPS CAGR, 5 years (%)
11.49

Source: quantro_screener_metrics_job · as of 2026-10-23

Annual summary

Year endedRevenue (₹ Cr)PAT (₹ Cr)EPS (₹)
Mar 20262,762.9504.830.13
Mar 20252,461.4487.129.14
Mar 20242,226.6357.721.42
Mar 20232,016.9238.914.33
Mar 20222,087.4344.820.69

Source: finedge · as of 2026-07-21

Shareholding and promoter pledge

Promoter
53.21%
FII
17.18%
DII
21.38%
Public
7.87%
Promoter shares pledged
0%

Source: finedge · as of 2026-03-31

Similar companies

Source: quantro_company_profiles · as of 2026-10-23

Frequently asked questions

What does Dr Lal Path Labs Ltd do?
Dr. Lal PathLabs Ltd. engages in the business of running laboratories for carrying out pathological investigations. The company is headquartered in Gurgaon, Haryana and currently employs 4,048 full-time employees. The company went IPO on 2015-12-23. The firm is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Company’s subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.
Which sector is Dr Lal Path Labs Ltd in?
Dr Lal Path Labs Ltd is in the Healthcare Service Provider sector, Healthcare Services industry.
What are Dr Lal Path Labs Ltd's latest annual revenue and profit?
For the year ended Mar 2026: revenue 2762.90 Cr, profit after tax 504.80 Cr.
What is the promoter holding and pledge in Dr Lal Path Labs Ltd?
Promoter holding is 53.21%; pledged shares are 0.00% of the promoter holding.
Which companies are similar to Dr Lal Path Labs Ltd?
Companies in the same sector of similar size: Vijaya Diagnostic Centre Ltd.
Want more history and detail? Create a free account for the full price history, quarterly statements, balance sheet and cash flow.

Figures computed 2026-10-23.